or Try an Advanced Search...

    Neuroendocrine Tumors Stocks List

    Symbol Grade Name % Change
    CRNX B Crinetics Pharmaceuticals, Inc. 1.82
    AQST D Aquestive Therapeutics, Inc. -3.06
    ABUS D Arbutus Biopharma Corporation 1.69
    RANI F Rani Therapeutics Holdings, Inc. -0.98
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Neuroendocrine Tumor Acromegaly Biopharmaceutical Disease Endocrine System Neuroendocrinology Organ Systems Acute Lymphoblastic Leukemia Alcohol Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Anaphylaxis Cancer Carcinoma Chemical Entities Chloroarenes Cholesterol Cyclophilin Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Neuroendocrine Tumors stocks.

    Symbol Grade Name Weight
    HRTS D Tema Cardiovascular and Metabolic ETF 4.31
    MNTL D Tema Neuroscience and Mental Health ETF 3.88
    SBIO C ALPS Medical Breakthroughs ETF 2.95
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.01
    PTH D Invesco DWA Healthcare Momentum ETF 1.68
    View all Neuroendocrine Tumors ETFs...
    Compare ETFs
    Compare HRTS to PTH Compare HRTS to SBIO Compare SBIO to BBC

        Neuroendocrine Tumors Stocks Recent News

        Date Stock Title
        Nov 20 RANI RANI: Third Quarter Update
        Nov 16 AQST Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?
        Nov 15 ABUS Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
        Nov 15 ABUS Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
        Nov 15 CRNX Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
        Nov 14 CRNX UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
        Nov 14 RANI Rani Therapeutics GAAP EPS of -$0.24 in-line
        Related Industries: Biotechnology
        Related Stock Lists: Neuroendocrine Tumor Acromegaly Biopharmaceutical Disease Endocrine System Neuroendocrinology Organ Systems Acute Lymphoblastic Leukemia Alcohol Amyloid Amyloidosis Amyotrophic Lateral Sclerosis Anaphylaxis Cancer Carcinoma Chemical Entities Chloroarenes Cholesterol Cyclophilin Diabetes
        Neuroendocrine Tumors

        Neuroendocrine tumors (NETs) are a type of cancer that can occur in various parts of the body, including the lungs, pancreas, and gastrointestinal tract. They are usually slow-growing and can produce hormones that can cause a variety of symptoms. Treatment for NETs depends on the size and location of the tumor, as well as the patient's overall health.

        Browse All Tags